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Specialty Update
What’s New in Spine Surgery
By Keith H. Bridwell, MD, Paul A. Anderson, MD, Scott D. Boden, MD, Alexander R. Vaccaro, MD, and Jeffrey C. Wang, MD
What’s New in the Treatment of the Cervical Spine
Many controversies still exist with regard to the surgical
treatment of cervical spine pathology. The role of allograft,
autograft, plate fixation, and bone morphogenetic protein is
not entirely clear. There is still debate about the surgical
treatment of myelopathy anteriorly as opposed to posteriorly.
Clearly, there is substantial anatomic variation in the location
of the vertebral artery. Disc arthroplasty for the cervical spine
continues to appear to be a viable option for patients with
single-level pathology.
Anterior Cervical Fusion
Despite interest in motion preservation, cervical fusion re-
mains a common and highly successful surgical approach for
the treatment of radiculopathy and myelopathy. Recently re-
ported clinical outcomes following single-level fusion have
shown that a substantial reduction in pain and disability occurs
in about 90% of cases. Improvement in overall health-related
quality of life, as measured with the Short Form-36 (SF-36),
was substantial compared with that occurring after total hip or
total knee arthroplasty. Multivariable analysis showed that the
presence of litigation and narcotic use were negative predictors
of success, whereas high levels of preoperative disability and
sensory loss were positive predictors. Following allograft and
plate fixation of a single level, fusion success occurred in 95%
of the patients as reported in three randomized clinical trials.
To enhance fusion success, other biologic and reconstructive
measures have been utilized. Pulsed electromagnetic field
stimulation following anterior fusion showed improved fusion
success as compared with controls at six months but no dif-
ference at twelve months and showed no improvement in any
clinical outcome parameters. Recombinant human bone
morphogenetic protein-2 (rhBMP-2) is an alternative, espe-
cially in cases of multilevel fusion, after which the pseudar-
throsis rate is known to be increased. The United States Food
and Drug Administration (FDA) recently warned against the
off-label use of rhBMP-2 in the cervical spine because of severe
inflammatory reactions causing dysphagia, hematoma, and
airway obstruction requiring secondary surgery. This is of
particular concern when used anteriorly in the cervical spine.
Dosing may be an important factor, with recommended doses
in the cervical spine being 0.4 to 0.7 mg/level. However, the
rate of success of anterior cervical fusion with rhBMP-2 after
multilevel procedures is lower than desired. Another common
method to enhance fusion is immobilization, although no
consensus has been reached regarding specific indications. In a
study of >550 patients who were managed with a plate and
allograft at a single level, the use of an orthosis made no dif-
ference in fusion success and was associated with a delayed
return to activities, including work.
Myelopathy
Myelopathy due to cervical cord compression is expected to
increase in frequency with the aging population and is in-
creasingly the focus of research. Assessing the severity of my-
elopathy is difficult as symptoms are subtle and physical
findings are subjective. More quantitative assessment methods
are needed so that the effectiveness of various treatments can
be measured. Several quantitative methods that have been
shown to be reliable and valid include the evaluation of grip
strength with use of a standard dynamometer, the ten-second
step test, and the ten-second open-and-close hand test. In the
latter two tests, normal subjects can perform these movements
more than fifteen and twenty times, respectively. Another test
is the triangle step test, in which sitting subjects repetitively
touch the apices of a 30-cm equilateral triangle for twenty
seconds. Normal patients can perform twenty-five touches,
whereas myelopathy patients complete fewer than fifteen
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touches. The correlation of the triangle test to disability scores
is excellent. The most common measure of myelopathy is the
Japanese Orthopaedic Assessment (JOA) score (range, 0 to 17)
and the modified JOA (mJOA) (adapted for use in Western
society). In a large prospective study evaluating the outcomes
of cervical myelopathy, the mJOA and the Neck Disability
Index (NDI) were tested for responsiveness as compared with
the SF-36. Results demonstrated that the NDI correlated better
with the SF-36 change, although both had acceptable psy-
chometric properties. In that study, neurologic improvement
occurred in 85% of patients, with the absolute improvement in
the mJOA averaging 2.7 points.
The surgical treatment of myelopathy has changed over
the last decade from the anterior approach to the posterior
approach with the widespread use of laminoplasty. One of the
major disadvantages of this technique is the higher incidence
of C5 motor root paralysis, which occurs in 3% to 10% of
patients. Risk factors include the presence of C5 foraminal
stenosis and excessive posterior cord shift. A strong association
with C5 palsy was seen in patients with a triad of radiographic
findings, including C5 foraminal stenosis, a spinal cord an-
teroposterior diameter at C5 of £7 mm, and a cord-laminar
angle ‡30. The latter is formed by intersecting lines along the
anterior aspect of the spinal cord and the ipsilateral lamina.
The method to prevent this complication in patients with
unfavorable anatomy remains elusive, although a simultaneous
decompression of the C5 nerve root may be indicated.
Vertebral Artery
The relationship of the vertebral artery to screw placement,
especially in the upper cervical spine, continues to receive at-
tention. Osseous anatomic abnormalities strongly correlate
with vascular anomalies, with surgical implications. In one
study, 6% of all patients who were studied with computed
tomographic angiography had vertebral artery anomalies at
C1-C2, the majority of which had surgical relevance. In such
cases, computed tomography angiography or magnetic reso-
nance angiography is recommended before surgery. Additional
studies of the vertebral artery in the subaxial cervical spine also
show a higher rate of abnormalities than previously identified.
The artery enters the spine at C6 in only 94.6% of cases,
whereas anomalous entries occur at C7, C5, and C4 in 1.6%,
3.3%, and 0.3% of cases, respectively. Consistent with the
upper cervical spine, a small transverse foramen was associated
with absence (and therefore an anomalous position) of the
vertebral artery. The significance of these anatomic studies was
borne out in one series by the identification of screw mis-
placement involving the foramen transversarium in as many as
20% of screws placed at C1 and C2. Fortunately, arterial injury
and neurologic deficits were rare.
Cervical Disc Arthroplasty
Two recent studies evaluated the twenty-four-month results of
two randomized controlled trials in which cervical arthroplasty
was compared with fusion following discectomy for the
treatment of single-level radiculopathy or myelopathy. Both
studies, along with a previously published investigation,
demonstrated equal or greater pain relief and functional out-
comes in association with the experimental treatment. Adverse
events appeared to be similar, although the rate of reoperations
was lower for the arthroplasty group at the time of short-term
follow-up. Longer follow-up studies at four years showed ex-
cellent maintenance of satisfactory outcomes in both the ar-
throplasty and fusion groups. Longer follow-up is needed to
measure the effectiveness of arthroplasty in reducing adjacent-
segment degeneration and the durability of the devices.
What’s New in Biologic Topics Related to the Spine
Biologics continued to be a major focus in spine research and
the development of new products for patients with spinal
disorders in 2008. Most of the current attention remains on
bone formation, but research also continues to investigate the
role of biologics in retarding or reversing intervertebral disc
degeneration. In patients undergoing spine fusion, the choice
of bone-graft substitutes remains an emotional rather than
scientifically driven decision for many, but the desire to
eliminate the need for autogenous iliac crest bone graft harvest
is strong. Since the FDA’s post-marketing approval of rhBMP-2
in 2002 and its issuance of a Humanitarian Device Exemption
for rhBMP-7 late in 2004, differences in the clinical perfor-
mance of these two proteins have become more striking and
local side effects resulting from physician-directed uses have
become more evident. While an increasing amount of research
continues to be focused on understanding the biology of the
intervertebral disc and developing biologic strategies to retard
or reverse degeneration, these treatments remain years from
routine clinical use.
Recombinant Osteoinductive Proteins
Recombinant human growth and differentiation factor-5
(rhGDF-5; DePuy Biologics, Johnson and Johnson, Raynham,
Massachusetts) has yielded inconsistent results in spine fusion
clinical trials, and the future use of GDF-5 for spine fusion
remains uncertain. Basic-science studies continue to investi-
gate this protein as an anabolic stimulus of disc cartilage me-
tabolism. GDF-5 may reappear as a potential intradiscal
biologic therapy in the future.
Most clinical studies involving the use of rhBMP-7 (OP-
1; Stryker Biotech, Hopkinton, Massachusetts) for postero-
lateral spine fusion have yielded fusion success rates of 50% to
70% on the basis of radiographs or of 45% on the basis of
surgical exploration. The failure to achieve a >90% fusion
success rate has been attributed to the use of a ‘‘more
challenging’’ model involving spine fusion without instru-
mentation, although at least one study of fusion with
instrumentation showed a success rate of approximately 50%
in association with OP-1, which is similar to the outcomes
reported for the studies of fusion without instrumentation and
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is still not at a level equal or superior to that associated with the
use of autograft. It is believed that data from the United States
clinical trial of OP-1 for posterolateral fusion remain under
review by the FDA for consideration for post-marketing ap-
proval. Several preclinical OP-1 studies are now showing that
there may indeed be a dose response, as seen with other BMPs,
and that the current clinical formulation (concentration) may
be insufficient for posterolateral spine fusion.
Although rhBMP-2 (INFUSE; Medtronic Sofamor
Danek, Memphis, Tennessee) has been approved by the FDA
for anterior lumbar interbody fusion, several physician-
directed studies have evaluated the outcomes of transforaminal
and posterior interbody fusion as well as posterolateral spine
fusion. One study with a two-year follow-up demonstrated an
overall fusion success rate of 95% in association with the use of
rhBMP-2 at doses of 10 mg/level without autogenous bone for
anterior spinal fusion, 20 mg/level with local bone graft and a
ceramic bulking agent for posterolateral spine fusion, and 40
mg/level with a ceramic bulking agent and no local bone for
posterolateral spine fusion.
A primary concern associated with physician-directed
use of recombinant BMPs relates to local adverse events. The
most commonly reported local side effects are heterotopic
bone formation in the surgical approach track, transient ra-
diculitis, transient vertebral body bone resorption when used
near exposed cancellous bone, and sterile seroma fluid col-
lections and/or local edema. Most of these local side effects are
believed to be related to the surgeon using too much BMP
either by increasing the concentration of the growth factor or
overstuffing the defect, which can result in a higher local
concentration or leakage of BMP into the surrounding tissues.
BMP-induced radiculitis typically occurs seven to ten days
after surgery and persists for a variable length of time.
Sanfilippo et al. reported that nine of thirty-nine patients who
were managed with a transforaminal interbody fusion with use
of BMP-2 experienced radiculitis lasting at least six months.
The mean duration of symptoms was at least 13.4 months, and
some patients continued to have pain at the time of the latest
follow-up.
There have been several reports of psoas muscle ossifi-
cation in association with rhBMP-2/absorbable collagen
sponge implantation in the posterolateral spine. These cases
are quite rare, but there appears to be something unique about
the psoas muscle, compared with the other posterior spinal
muscles, that may make it more susceptible to BMP-2-induced
heterotopic ossification in some individuals. The risk factors
that lead to this rare side effect are not known but may involve
both patient genetic predisposition as well as surgical violation
of the intertransverse membrane providing access to the psoas
muscle.
The potential for osteolysis due to osteoclastic stimula-
tion by BMPs remains a concern, especially when the vertebral
end plates have been extensively decorticated, providing direct
access to the cancellous bone and bone marrow of the vertebral
body. Several authors have reported transient peri-implant
resorption, which usually resolves spontaneously after six
months and usually does not impact healing. The phenome-
non was first observed by Burkus et al. when rhBMP-2 was
used inside threaded cortical bone allograft dowels and
more recently by Meisel et al. when used inside a polyether-
ether-ketone (PEEK) interbody cage. Although those authors
did not report adverse clinical outcomes related to the oste-
olysis, McClellan reported graft subsidence, loss of end plate
integrity, and a lack of progression to fusion at segments with
bone loss. Among patients with postoperative computed
tomography scans following transforaminal interbody fusion
with BMP-2, twenty-two (69%) of thirty-two levels demon-
strated osteolysis, and, of these, eleven levels demonstrated
ongoing failure to progress to fusion.
Several authors have reported severe perioperative
swelling in the anterior cervical spine, sometimes when ex-
cessive BMP-2 doses were used or when the BMP was placed
outside the structural cage/implant. This complication often
becomes apparent several days following surgery and has ne-
cessitated reintubation or tracheostomy because of the risk of
respiratory arrest. On July 1, 2008, the FDA issued a public
health notification of life-threatening complications associated
with the use of BMPs in the cervical spine. Surgeons who are
observing these local side effects with any regularity should
carefully examine their technique and should avoid using ex-
cessive amounts of BMPs in small spaces or overpacking of the
BMP implants. Given the high success rate for anterior cervical
fusion in healthy patients with allograft and plating, surgeons
must carefully balance any increased risk of side effects asso-
ciated with the use of BMP with the actual need for the in-
creased healing potential in their specific patient. Although
several physician-directed studies in which BMP has been used
successfully for anterior cervical fusion have been reported,
this use is off-label at the present time.
Other studies have answered three common questions
about rhBMP-2. First, repeated exposure to BMP-2 does not
seem to impact its effectiveness, suggesting that the transient
antibodies that develop in 7% to 10% of patients do not have
any effect on clinical bone formation. Also, the use of a post-
operative drain does not seem to diminish the effectiveness of
BMP-2 when used for posterolateral spine fusion. Finally, the
use of rhBMP-2 in the presence of anterior spinal infection was
reported to be safe and effective, with none of twenty patients
having a persistent or recurrent infection after a mean duration
of follow-up of forty months.
Other Bone-Graft Substitutes
Although much focus remains on recombinant osteoinductive
proteins, their relatively high cost has continued to encourage
research involving other bone-graft solutions. There is con-
tinued interest in mesenchymal stem cells for bone and car-
tilage regeneration. In rodent models, both fat-derived and
bone marrow-derived mesenchymal stem cells appear to be
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capable of expressing the BMP-2 gene and producing spine
fusion. One preclinical study concluded that delivery of mes-
enchymal stem cells with rhBMP-2 enabled the use of a much
lower dose of BMP than was the case for cell-less delivery
strategies. As for strategies that propose to use mesenchymal
stem cells alone as an alternative to recombinant BMPs, the
number of stem cells present in bone marrow is relatively
small, and, without specific signals (e.g., BMP), it is not clear
whether sufficient numbers of cells are present to consistently
initiate bone formation in challenging environments such as
the site of a spine fusion.
Biologic Treatments for Disc Degeneration
Progress toward biologic treatments to prevent or retard disc
degeneration continued at a slow pace. Animal evidence of
beneficial effects of recombinant BMPs (BMP-7, BMP-2, GDF-
5) on disc metabolism has prompted the planning of a clinical
trial to investigate the response in humans. One group re-
ported that the delivery of a ‘‘cocktail’’ of anabolic factors to
the rabbit disc by means of adenovirus was a more effective
strategy than the delivery of single proteins. BMP-7 has been
shown to prevent apoptosis of human disc cells in vitro, pos-
sibly through the inactivation of caspase-3. Simvastatin has
been shown to promote chondrogenesis of rat intervertebral
disc cells by upregulating BMP-2. Although the clinical use of
biologics to treat disc degeneration is a long way off, it is worth
monitoring developments in this area, which could ultimately
be an important technology for the treatment and prevention
of many degenerative spine disorders.
What’s New in Spinal Deformity Surgery
The Scoliosis Research Society (SRS) Annual Meeting was
held in Salt Lake City, Utah, September 10 to 13, 2008. The
Harrington lecturer was Marc Asher, MD, who spoke on
Dr. Paul Harrington’s contributions and perspective. Lifetime
Achievement awards were given to John E. Hall, MD, and to
Jacquelin Perry, MD, DSc, and George Thompson, MD,
completed a two-year term as President. SRS globalization
efforts have expanded over the last five years. The SRS Global
Outreach Program currently represents a service initiative with
nine endorsed sites on four continents, and the development of
worldwide regional courses has focused on international ed-
ucational activities and the building of professional
relationships.
Adolescent Idiopathic Scoliosis
Work continues on the genetic profiling of teenagers with id-
iopathic scoliosis. Ward and Ogilvie presented evidence sug-
gesting that it may now be possible to predict which curves will
progress into the surgical range and which will be resistant to
bracing. This may have a profound impact on the nonopera-
tive treatment of idiopathic scoliosis.
Scoliosis surgeons continue to debate the surgical
treatment of double-major curves and ‘‘false’’ double-major
curves with regard to fusion of the lumbar curve. A multi-
center study by the Harms Study Group concluded that pa-
tients with preserved lumbar motion had greater function and
satisfaction at two years after surgery in comparison with those
who had a lumbar curve that was fused. A group of authors
from Turkey concluded that selective thoracic fusion may be
considered if the lumbar curve is <50 and demonstrates
>50% flexibility.
The topic of thoracic pedicle screws for the treatment of
adolescent idiopathic scoliosis remains controversial. One re-
port by the Spinal Deformity Study Group suggested that the
correction of a thoracic deformity was related to the number of
fixation points rather than which specific type of bone anchor
was implemented. Several studies have suggested that sub-
laminar wires are kyphogenic in the thoracic spine and that
thoracic pedicle screws have a lordosing tendency, especially if
a direct apical derotation maneuver is performed. Researchers
at Cincinnati Children’s Hospital documented an 80% increase
in surgical costs for idiopathic scoliosis treatment over a seven-
year time frame, attributed mostly to the increased use of
pedicle screws.
Researchers from Texas Scottish Rite Hospital for Chil-
dren in Dallas and Washington University in St. Louis inde-
pendently assessed the benefits of halo traction for the
treatment of severe deformities. Both groups of researchers
concluded that halo traction had a high benefit-to-risk ratio,
with improved overall correction and a reduced risk of neu-
rologic deficit in association with the ultimate surgery.
Adult Spinal Deformity
It is generally accepted that the surgical treatment of adult
spinal deformity demands a solid fusion, and a long construct
from the thoracic spine to the sacrum is often needed. The
annual meeting of the SRS highlighted much of the ongoing
research in this difficult treatment group. Contrasting views on
the role of anterior surgery in this patient subset were pre-
sented. Regardless of which approach is utilized, patient out-
comes at a minimum of two years of follow-up were good if a
solid fusion was achieved and complications were minimized.
The results supported sagittal plane balance (not coronal plane
correction/balance) as the primary radiographic factor in de-
termining the outcome. Some of the trends gleaned from re-
cent presentations include decreased use of circumferential
fusion; increased use of bilateral pedicle screw fixation and
multiple fixation points in the sacropelvic unit, usually with
use of iliac screws; and frequent off-label use of BMP to en-
hance fusion rates in both anterior and posterior fusions. To
date, we are not aware of any reports of local or systemic
complications related to the use of BMP during adult spinal
deformity surgery in contrast to its use during anterior cervical
spine fusion. Nonetheless, the use of BMP for the treatment of
adult spinal deformity will remain highly controversial until it
is approved by the FDA for multilevel posterior fusion and
more than one vendor distributes it.
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Complications of adult spinal deformity surgery were
the focus of many presentations. Additional data on cata-
strophic failures of the proximal adjacent segment in pedicle
screw constructs were presented. The patients who were found
to be at greatest risk were women over the age of sixty years
with sagittal imbalance, obesity, osteopenia, and a substantial
sagittal plane correction. Alternative methods of fixing the
cephalad level with something other than pedicle screw im-
plants are being evaluated.
Age appears to be a primary determinant of complica-
tion rates after spinal deformity surgery. Patients over the age
of sixty years are more likely to experience complications than
those in the forty-to-sixty-year-old age group. Nonetheless,
data suggest that the postoperative incremental improvement
in outcome according to SRS and Oswestry Disability Index
measures is identical for patients in the forty-to-sixty-year-old
age group and those in the more-than-sixty-year-old age
group. It appears that complications reduce the likelihood of
benefit from surgery, but they do not preclude benefit as long
as the complications are not catastrophic (major paralysis,
blindness, death).
Neuromuscular Scoliosis
There is a strong trend away from performing anterior and
posterior surgery for fusions to the sacrum in patients with
cerebral palsy. The current preferred method is intraoperative
traction and a long posterior procedure extending from the
upper thoracic spine to the sacrum and pelvis. In most cases,
halo traction and posterior techniques will suffice. The
crankshaft phenomenon is a substantial concern for juvenile
patients with neuromuscular scoliosis who require a long fu-
sion. One study suggested that anterior surgery did not pre-
clude the crankshaft phenomenon and that those at greater
risk were the particularly young patients (eight years of age or
younger) and those who did not have a long fusion, defined as
one extending from above T5 and down to the sacrum as
opposed to stopping at L4 or L5. Pedicle screw fixation may
improve the correction, especially in patients with Duchenne
muscular dystrophy.
Infections are a substantial problem in juvenile patients
with neuromuscular scoliosis. A study from the Shriners
Hospital-Chicago demonstrated an 11.2% infection rate in
patients with cerebral palsy and a 19.2% rate in patients with a
myelomeningocele. The majority of patients with deep infec-
tions ultimately required implant removal.
Early-Onset Scoliosis
The term ‘‘early onset’’ refers to scoliosis that presents before
the age of six years. Etiologies include congenital, infantile, and
early juvenile idiopathic scoliosis; chromosomal syndromes;
and genetic connective-tissue disorders. These are all circum-
stances in which traditional bracing does not control the spinal
deformity. There usually is substantial risk of either pulmonary
compromise or a neurologic deficit if the disorder is not
treated. Spinal fusion is not a good alternative because there is
much growth remaining. Strategies include dual growing rods,
the Vertical Expandable Prosthetic Titanium Rib technique,
vertebral body stapling, and the use of multiple corrective
casts. No one technique is completely effective. Although there
is no statistical proof that neuromonitoring reduces the
prevalence of neurologic deficit, there is a consensus that it is
highly advisable.
High-Grade Developmental Spondylolisthesis
Sacral doming is thought to be an early sign of progressive
high-grade spondylolisthesis and ‘‘impaired spinopelvic
alignment.’’ Thus, this finding is considered by many to signal
an indication for early intervention and surgery. The classic
high-grade developmental spondylolisthesis, which benefits
from a reduction with instrumentation, is one with lumbo-
sacral kyphosis, retroversion of the sacrum and pelvis, com-
pensatory proximal lumbar hyperlordosis, and positive sagittal
balance. Surgical treatment should be aimed at reducing the
lumbosacral kyphosis and correcting the pelvic retroversion so
that the anterior spinal gravity line falls through the sacrum
and the lumbar segments above can spontaneously adjust to a
more normal segmental sagittal alignment.
What’s New in Spinal Cord Injury
A study from the 2008 American Spinal Injury Association
(ASIA) meeting reported that, on the basis of the prevalence of
250,000 individuals with spinal cord injury alive in the United
States today, the aggregate cost for managing patients who have
a spinal cord injury is $22.16 billion per year. Managing pa-
tients who have a spinal cord injury is a major social issue,
particularly in the setting of a national fiscal healthcare crisis.
As this population continues to increase, it is imperative that
strides are made in the management and evaluation of these
patients.
This past year was particularly exciting for surgeons and
scientists in the field of spinal cord injury. Emphasis was placed
on the evaluation of functional outcomes and prognostic in-
dicators of mortality following spinal cord injury. The first
stem-cell trial for spinal cord injury was initiated, and pre-
liminary results evaluating the role of early surgical decom-
pression following spinal cord injury were reported.
Outcome Measures
The 2006 National Institute on Disability and Rehabilitation
Research (NIDRR) Spinal Cord Injury Measures Meeting
continued to generate reports in The Journal of Spinal Cord
Medicine. Reports from 2008 focused on the evaluation of
outcome measures and measures of functional recovery. One
study provided guidelines for the evaluation of outcome
measures for spinal cord injury, emphasizing the methods and
principles important in a systematic review. This study was
based on the notion that, despite the fact that many outcome
measures are described as ‘‘reliable and valid,’’ there are no
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specifications of how reliable or how valid they are or in what
set of patients they can be used. The authors devised a 5-point
method of grading measures of health, function, and quality of
life and applied it to spinal cord injury outcome measures.
Another study from the Measures meeting focused on the
evaluation of functional status following spinal cord injury as
neurologic recovery does not always translate into functional
recovery. A multinational work group analyzed four functional
outcome scoring methods and concluded that the latest ver-
sion of the Spinal Cord Independence Measure (SCIM III)
should be the primary functional recovery outcome measure
for spinal cord injury.
Proceedings from the 2008 ASIA meeting focused on
mortality following spinal cord injury. One study evaluated the
risk of mortality in adults and found that subsequent injuries,
amputations, fractures, and depressive symptoms should be-
come the focus of prevention efforts. These conditions serve as
indicators of a high risk of mortality and the need for imme-
diate intervention. Another study evaluated whether age at the
time of the injury and comorbidity indices are predictors of in-
hospital mortality and length of stay in a spinal cord injury-
care facility. Clinical outcomes and mortality were significantly
associated with age, the Charlson Comorbidity Index (CCI),
the number of ICD-9 codes, and the Cumulative Illness Rating
Scale. Length of stay in the acute spinal cord injury facility was
only directly correlated with the CCI. The same group of in-
vestigators also reported on mortality and neurologic out-
comes in the geriatric population following spinal cord injury.
They found that elderly individuals had significantly greater
mortality rates at all time points following spinal cord injury
when compared with younger patients. However, among sur-
vivors, age was not correlated with motor or sensory recovery
or pain scores. This finding provides a rationale for individ-
ualizing treatment approaches for elderly patients with spinal
cord injury as the opportunity exists for neurologic recovery in
this patient subgroup.
Evaluation and Surgical Management
One study that was presented at the 2008 ASIA meeting
evaluated the use of magnetic resonance imaging as a predictor
of neurologic improvement on the basis of the ASIA impair-
ment scale. Data collected from sixty patients showed a trend
for neurologic improvement with the absence of hemorrhage
and a smaller length of lesion. Edema, disc herniation, soft-
tissue injury, cord compression, and canal compromise did not
significantly correlate with neurologic improvement.
Although animal studies have demonstrated increased
functional recovery in association with early surgical decom-
pression, the lack of Level-1 clinical data continues to generate
debate over whether early surgical decompression following
spinal cord injury is beneficial. This led to the creation of the
Surgical Treatment for Acute Spinal Cord Injury Study
(STASCIS), a multicenter, randomized, prospective trial to
evaluate the timing of decompression following spinal cord
injury. Patients are randomized to early decompression (per-
formed less than twenty-four hours after an injury) or late
decompression and are evaluated on the basis of radiographic
and functional outcomes. The initial results of the STASCIS
trial were presented at the 2009 AAOS Federation of Spine
Associations Annual Meeting. As of January 2009, there were
276 patients in the database available for analysis. At the
six-month time point, there was no significant difference in
improvement in the ASIA grade between the two groups.
However, at one year of follow-up, there was a significantly
greater proportion of patients in the early decompression group
who had at least two grades of improvement as compared
with the late group. Although not significant, there was also
a higher percentage of complications in the late group. Pre-
liminary results showed that early decompression is safe and
feasible, with major hurdles being delay in admission, imaging,
and operating room availability. We eagerly await the final
results of the STASCIS trial, which will provide Level-1 evidence
for whether early surgical decompression is beneficial.
Neuroprotective Treatments
Trauma to the spinal cord results in an immediate patho-
physiologic response characterized by loss of electrolyte ho-
meostasis, local ischemia, free radical formation, and
inflammation. The National Acute Spinal Cord Injury Studies
(NASCIS) II and III resulted in setting a national trend for
using methylprednisolone as a neuroprotective agent when
administered within the first eight hours after a spinal cord
injury. However, after several published analyses of the litera-
ture and a critical review of subgroups of the study population,
improvement in functional recovery with the use of methyl-
prednisolone appears not to be clinically important. Despite
these reports and the fact that numerous professional societies
have concluded that methylprednisolone is not clinically in-
dicated, surgeons continue to use it. A recent analysis of the
North American Spine Society membership revealed that 86%
of surveyed surgeons reported using the NASCIS protocol
when managing patients who have spinal cord injury. The
most commonly stated reason is fear of litigation, with only a
quarter of respondents indicating that methylprednisolone was
given because they believed it to be beneficial. Interestingly, a
recent study indicated that 24% of surveyed Canadian sur-
geons currently prescribe methylprednisolone, whereas 76%
prescribed it five years ago. The difference in practice patterns
between the United States and Canada may be secondary to the
litigious environment of the United States.
Seventy-one thousand fans watched the Buffalo Bills
2007 season opener as Kevin Everett suffered an incomplete
spinal cord injury resulting from a cervical fracture-dislocation
after tackling an opponent. Systemic hypothermia was initiated
during transportation to the hospital, where he subsequently
underwent decompression and fusion of the cervical spine.
Four months later, he was walking. There continues to be a
flurry of public interest associated with the use of hypothermia
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in the setting of spinal cord injury. From a neuroprotective
standpoint, hypothermia slows enzymatic activity and reduces
energy requirements. A recent review of animal and clinical
studies on the use of hypothermia was performed. Animal data
on systemic and local hypothermia are mixed, with some
studies demonstrating a benefit and others demonstrating no
effect. Local hypothermia was actively studied in the 1970s for
the treatment of human acute traumatic spinal cord injury, but
no case series of this intervention has been published since
1984, to our knowledge. No peer-reviewed clinical literature
that describes the application of systemic hypothermia in acute
traumatic spinal cord injury could be identified. Therefore,
while a rationale may exist for the use of local or systemic
hypothermia following spinal cord injury, there are few animal
or clinical data to support its use.
Emerging Therapies
The reversal of paralysis after spinal cord injury through cell-
based strategies aims to replace oligodendrocytes or neurons
lost to injury and to enhance the environment for axonal re-
generation. Two therapies of particular interest this year in-
clude olfactory ensheathing cells and human embryonic stem
cells (hESC).
Olfactory ensheathing cells are a specialized glial cell
with the unique ability to facilitate the passage of new axons
from the peripheral nervous system to a target neuron in the
central nervous system. Human studies of olfactory en-
sheathing cell transplantation following spinal cord injury have
been performed in China, Portugal, and Australia. In 2008, the
outcomes of the Australian Phase I/IIa feasibility and safety
study were reported. In the six patients who were enrolled in
the study, there were no adverse findings three years after
autologous transplantation of olfactory ensheathing cells.
Magnetic resonance images made at three years showed no
change from preoperative magnetic resonance images, and
there were no substantial functional changes in any of the
patients. The investigators concluded that transplantation of
olfactory ensheathing cells into the injured spinal cord is fea-
sible and safe for up to three years after implantation. The
results of that study are muted by the small number of patients
in which the olfactory ensheathing cells were implanted.
Just days after President Obama’s inauguration, the FDA
granted clearance for the first-ever Phase-1 clinical trial of
human embryonic stem cells in patients with acute spinal cord
injury. GRNOPC1 (Geron, Menlo Park, California) contains
human embryonic stem cell oligodendrocyte progenitor cells
that have demonstrated promising results in animal models.
Oligodendrocyte progenitor cells that have been injected seven
days after a spinal cord injury in rats have been shown to
differentiate into oligodendrocytes and ultimately to enhance
remyelination and to improve motor function. The ultimate
goal is to achieve restoration of function in patients by in-
jecting oligodendrocyte progenitor cells directly into the in-
jured spinal cord. Patients eligible for the Phase-I trial must
have a complete spinal cord injury and must agree to have the
drug injected between seven and fourteen days after the injury.
As many as seven medical centers will be selected to participate
in this landmark trial.
President Obama fulfilled his campaign promise of
overturning the previous administration’s ban on federal
funding of stem-cell research by signing an executive order in
March 2009. This will undoubtedly increase the pace of human
embryonic stem-cell research. However, caution should be
exercised when counseling patients on the merits of stem-cell
therapy as patients with spinal cord injury are highly vulner-
able to the investment of hope in improvement or cure. A
study at the 2008 ASIA meeting evaluated the web sites of
twelve commercial entities providing cellular or tissue thera-
peutics to patients with spinal cord injury. The authors found
that only 25% of the entities had reported efficacy and safety
data in peer-reviewed journals, with 0% conducting a placebo-
controlled study. Two-thirds utilized logos suggesting dramatic
recovery or explicitly used the terms ‘‘miracle,’’ ‘‘cure,’’ or
‘‘breakthrough.’’ Until there is Level-1 clinical evidence that
demonstrates that human embryonic stem cells lead to im-
proved function, clinicians have an ethical responsibility to
present peer-reviewed data to patients that provide a realistic
outlook of proposed treatments.
What’s New in the Treatment of the Lumbar Spine
Lumbar spine disorders affect a substantial portion of the
population, and research into the treatment and pathogenesis
of these disorders continues to advance each year. As always,
novel technology is of high interest, but better studies evalu-
ating outcomes and results are also gaining interest.
Surgical Outcomes
Outcomes studies were highly regarded this past year, and the
results of operative and nonoperative treatment comparisons
are showing some advantages for surgical treatment. Data from
the Spine Patient Outcomes Research Trial (SPORT) were
presented at several meetings. With use of this database, pa-
tients with degenerative spondylolisthesis and spinal stenosis
were studied specifically with regard to the location of the
primary pain being either leg pain or low back pain. Both
operative and nonoperative treatments were compared in this
group. Operative treatment resulted in better outcomes in
comparison with nonoperative treatment for all patients in
the study, regardless of the location of the primary pain.
However, patients with primary leg pain improved more with
surgical treatment in comparison with patients with primary
back pain.
In the same group of patients, radiographic parameters
that categorized the grade of listhesis, the disc height, and the
amount of mobility of the spondylolisthesis were also studied.
The study attempted to define a relationship between these
radiographic parameters and the outcomes of operative and
nonoperative treatments. Regardless of any radiographic pa-
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rameters, patients managed operatively improved more than
those managed nonoperatively. The study demonstrated that
patients with higher grades of listhesis (grade II as compared
with grade I) and those who were stable with regard to angular
and translational motion had greater improvement with op-
erative treatment.
This group also was studied with regard to baseline
characteristics (sex, age, and psychological and medical con-
ditions), and the patients with degenerative spondylolisthesis
were compared with those with spinal stenosis without
spondylolisthesis. The investigators found that the two groups
had similar baseline characteristics, but the patients with de-
generative spondylolisthesis improved more after surgery
when compared with those with only spinal stenosis. As these
two groups are often combined in clinical studies, future
studies should separate these two distinct pathologies.
Psychological Screening
The outcomes for patients with spinal disorders are often
influenced, both operatively and nonoperatively, by psychologi-
cal disorders and patient distress. A study was performed to
study the ability of spine specialists to detect psychological dis-
tress. This prospective, blinded study examined 400 patients who
presented for an initial examination at a university spine center.
Four surgeons and four nonoperative spine specialists partici-
pated, and their clinical acumen was tested. Overall, this study
demonstrated that the majority of the patients had some degree
of psychological distress and that only 37% of the patients had no
psychological distress when tested. Perhaps more concerning was
the poor ability of the clinicians to detect this psychological
distress. Surgeons were correct only 40% of the time, whereas the
nonoperative specialists were correct 49% of the time.
Surgery in the Elderly Population
Studies evaluated the higher complication rates that have been
observed when surgery is performed in the elderly population.
A recent study examined the outcome of lumbar fusion in
patients over the age of sixty-five years. Fifty patients under-
going single-level lumbar decompression and posterolateral
fusion with autogenous iliac crest bone-grafting as part of a
control group for a randomized prospective study were in-
cluded. This carefully selected group of patients demonstrated
substantial benefits from surgical treatment, especially when
compared with a control population of younger patients and
the literature standards.
Novel Technology
Novel technology continues to attract attention as longer-term
follow-up is obtained. As part of an FDA randomized pro-
spective study, a pedicle-based dynamic stabilization system
was compared with lumbar posterolateral fusion after two
years of follow-up. Two hundred and fifty-three patients who
were managed with the dynamic device were compared with
114 patients who were managed with posterolateral fusion.
The results showed that the dynamic stabilization group was
comparable with the fusion group, with more favorable results
in the dynamic stabilization group with regard to improve-
ment in leg pain and back pain scores. Complication rates were
comparable between the two groups; however, the rate of screw
loosening was 0.88% in the dynamic stabilization group as
compared with 1.65% in the fusion group and the rate of
revision surgery was 11.1% in the former group as compared
with 9.6% in the latter group.
In a separate study, ninety-two patients who had been
managed with implantation of the same device for similar
indications were evaluated after as long as two years of follow-
up. In this population, 20% of the patients had events neces-
sitating revision surgery. Screw loosening accounted for 39%
of the complications; other complications included screw
breakage and cephalad spinal stenosis at the adjacent segment,
despite normal canal diameters at these levels at the time of the
index procedure.
Another study of the same device included thirty-eight
patients who were evaluated after two years of follow-up.
The patients were evaluated on the basis of radiographic and
magnetic resonance imaging parameters. Two-thirds of the
patients had implantation of the dynamic device only, and
one-third had implantation of the device along with an
adjacent-level fusion. The authors found that disc degenera-
tion at the level with the implanted dynamic device and
degeneration at the adjacent levels continued following sur-
gery. Degeneration at the adjacent segments appeared in 17%
of the patients. The authors concluded that the dynamic
stabilization device did not protect against adjacent-segment
or index-level degeneration; however, whether this progressive
degeneration is due to the surgery or represents the natural
history of lumbar degeneration is still up for debate.
Adjacent-Segment Degeneration
A long-term follow-up study with a minimum of five years and
an average of eight years of follow-up after lumbar fusion with
instrumentation was presented. Of the fifty-five patients,
twenty-one (38%) had development of adjacent segment de-
generation at the time of final follow-up. The authors found
that the restoration of lordosis of >10 in the fused segment
decreased the incidence of adjacent segment degeneration.
However, the development of adjacent-segment degeneration
was not correlated with a poor clinical result.
Evidence-Based Orthopaedics
The editorial staff of The Journal reviewed a large number of
recently published research studies related to the musculo-
skeletal system that received a Level of Evidence grade of I.
Over 100 medical journals were reviewed to identify these
articles, all of which have high-quality study design. In addi-
tion to articles published previously in this journal or cited
already in this Update, thirty-two level-I articles were identi-
fied that were relevant to spine surgery. A list of those titles is
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appended to this review following the standard bibliography.
We have provided a brief commentary about each of the ar-
ticles to help to guide your further reading, in an evidence-
based fashion, in this subspecialty area.
Upcoming Meetings and Events
Related to Spine Surgery
The Forty-fourth Annual Meeting of the Scoliosis Research
Society (SRS) will be held on September 23 through 26, 2009,
in San Antonio, Texas. It will be preceded by a one-day course
entitled ‘‘Complications: Pediatric and Adult’’ and a half-day
course entitled ‘‘Primer: Basic Spine Deformity,’’ both to be
held on September 22, 2009. Web site: www.srs.org
The Thirty-sixth Annual Meeting of the American Spinal
Injury Association (ASIA) and the United Spinal Association
(USA) will join forces in 2009 to present the ‘‘Congress on
Spinal Cord Medicine and Rehabilitation.’’ The Congress will
be held on September 23 through 26, 2009, in Dallas, Texas.
Web site: www.asia-spinalinjury.org
The Twenty-fourth Annual Meeting of the North
American Spine Society (NASS) will be held on November 10
through 14, 2009, at the Moscone Convention Center in San
Francisco, California. Web site: www.spine.org
The Thirty-seventh Annual Meeting of the Cervical
Spine Research Society (CSRS) will be held on December 3
through 5, 2009, in Salt Lake City, Utah. Web site:
www.csrs.org
The Federation of Spine Associations will present the
spine program at Specialty Day at the Annual Meeting of the
American Academy of Orthopaedic Surgeons (AAOS) on
Saturday, March 13, 2010, in New Orleans, Louisiana. Web
site: www.aaos.org
The Annual Meeting of the International Society for the
Study of the Lumbar Spine (ISSLS) will be held on April 12
through 19, 2010, in Auckland, New Zealand. Web site:
www.issls.org
The Seventeenth Annual International Meeting on Ad-
vanced Spine Techniques (IMAST) will be held on July 21
through 24, 2010, at the Sheraton Centre Toronto, Toronto,
Ontario, Canada. Web site: www.imastonline.com
NOTES: The authors thank Drs. Steve Mardjetko, Dan Riew, Harvinder Sandhu, and Brian Su for
peer-reviewing the sections of this manuscript.
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Annotated Evidence-Based Articles
Related to Spine Surgery
Ammendolia C, Furlan AD, Imamura M, Irvin E, van Tulder M. Evidence-
informed management of chronic low back pain with needle acupuncture.
Spine J. 2008;8:160-72.
This paper summarizes the best available evidence for the use of acu-
puncture for the treatment of chronic low-back pain. When compared with no
treatment, there is evidence that acupuncture is effective for pain relief and
functional improvement immediately after a series of treatment sessions and at
the time of short-term follow-up. Evidence suggests that, in comparison with
other treatments, acupuncture is not more effective for pain relief or functional
improvement. The most consistent evidence appears to be for the addition of
acupuncture to other therapies, which demonstrated more effective benefit in
terms of pain relief and functional improvement than the same therapies
without acupuncture.
Andersen LL, Kjaer M, Søgaard K, Hansen L, Kryger AI, Sjøgaard G. Effect of
two contrasting types of physical exercise on chronic neck muscle pain. Ar-
thritis Rheum. 2008;59:84-91.
This randomized controlled trial compared two types of physical ex-
ercise for the treatment of chronic neck pain associated with monotonous
work-related tasks. Patients were randomized to specific strength training of
the painful muscle (i.e., trapezius) or general fitness training without direct
involvement of the painful muscle. Specific strength training of the affected
muscle led to marked prolonged relief of neck muscle pain.
Bala MM, Riemsma RP, Nixon J, Kleijnen J. Systematic review of the (cost-)
effectiveness of spinal cord stimulation for people with failed back surgery
syndrome. Clin J Pain. 2008;24:741-56.
The authors conducted a systematic review to assess the cost effec-
tiveness of spinal cord stimulation in patients with chronic pain due to failed
back surgery syndrome. Only three studies met the inclusion criteria in terms
of cost effectiveness and suggested that spinal cord stimulation is both more
cost effective and less costly in the long term, but there is an initial high cost
associated with device implantation and maintenance.
Barth M, Weiss C, Thome´ C. Two-year outcome after lumbar micro-
discectomy versus microscopic sequestrectomy: part 1: evaluation of clinical
outcome. Spine. 2008;33:265-272.
In this randomized controlled trial involving eighty-four patients, the
two-year outcomes after microdiscectomy were compared with those after
microscopic sequestrectomy. The former method involved the insertion of
pituitary rongeurs and removal of intradiscal tissue, whereas the latter involved
only removal of the fragment outside the disc space. Recurrence rates of 10%
and 12%, respectively, were not significantly different, although clinical out-
comes were better in the sequestrectomy group. The conclusions of the study
support the opinion of many surgeons that a limited discectomy should be
performed. However, the authors did not adequately describe how much disc
material was removed or whether an anular incision was required. Thus, it is
unclear whether removal of free intradiscal material at the anular defect should
be performed.
Barth M, Diepers M, Weiss C, Thome´ C. Two-year outcome after
lumbar microdiscectomy versus microscopic sequestrectomy: part 2: radio-
graphic evaluation and correlation with clinical outcome. Spine. 2008;33:
273-9.
In a companion study, the authors assessed two-year radiographs and
magnetic resonance images in order to correlate imaging findings with clinical
outcomes. They found that microdiscectomy was associated with a greater loss
of disc height, endplate degeneration, and endplate changes as compared with
sequestrectomy. These radiographic findings correlated significantly with the
presence of low back pain. The conclusion, however, is limited because of the
exclusion of patients who did not have both preoperative and postoperative
studies and those who had second operations.
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Bronfort G, Haas M, Evans R, Kawchuk G, Dagenais S. Evidence-informed
management of chronic low back pain with spinal manipulation and mobili-
zation. Spine J. 2008;8:213-25.
This paper summarizes the best available evidence regarding the use of
spinal manipulation therapy and mobilization for the treatment of chronic low-
back pain. There is moderate evidence that spinal manipulation therapy with
strengthening exercise is similar in effect to prescription nonsteroidal anti-
inflammatory drugs with exercise in both the short term and the long term. There
is limited evidence that spinal manipulation therapy is better than physical therapy
and home exercise in both the short term and the long term.
Browder DA, Childs JD, Cleland JA, Fritz JM. Effectiveness of an extension-
oriented treatment approach in a subgroup of subjects with low back pain: a
randomized clinical trial. Phys Ther. 2007;87:1608-18; discussion 1577-9.
In this multicenter randomized clinical study, the effectiveness of an
extension-oriented treatment approach was compared with that of a lumbar
spine-strengthening exercise program for a subset of patients with low-back
pain and symptoms distal to the buttocks that centralized with extension
movements. Subjects in the extension-oriented group experienced greater
improvements on the basis of the Oswestry Low Back Pain Disability Ques-
tionnaire as compared with subjects who received trunk-strengthening exer-
cises at all time-points up to six months.
Carroll A, Barnes M, Comiskey C. A prospective randomized controlled study
of the role of botulinum toxin in whiplash-associated disorder. Clin Rehabil.
2008;22:513-9.
Botulinum toxin injections have been previously described as a treat-
ment for a variety of muscle injuries, including whiplash disorders. A ran-
domized controlled trial of patients with whiplash who had had symptoms for
longer than two months was performed. Thirty-one patients completed the
study and were managed with either botulinum toxin injection or saline so-
lution injection into four trigger points. Follow-up at three months showed
greater improvements and less chronic disability in the experimental botuli-
num toxin group. However, the conclusions are limited because of the small
number of patients, a 20% rate of loss to follow-up, and the short follow-up
interval.
Cohen SP, Hurley RW, Buckenmaier CC 3rd, Kurihara C, Morlando B,
Dragovich A. Randomized placebo-controlled study evaluating lateral branch
radiofrequency denervation for sacroiliac joint pain. Anesthesiology.
2008;109:279-88.
Denervation of the posterior sacroiliac innervation has been considered
to be a possible method to treat nonresponsive back pain. Ninety patients
were screened, of whom twenty-eight were randomized to sacroiliac joint
radiofrequency ablation or placebo (L4-L5 medial branch ablation). Despite
the small number of patients, pain relief and disability were significantly
improved in the sacroiliac joint denervation group. This study is limited by
the small number of patients and the potential bias of investigators toward
this procedure; however, additional study of this approach should be
forthcoming.
Dagenais S, Mayer J, Haldeman S, Borg-Stein J. Evidence-informed man-
agement of chronic low-back pain with prolotherapy. Spine J. 2008;8:203-12.
This paper summarizes the best available evidence regarding the use of
prolotherapy for the treatment of chronic low-back pain. Prolotherapy has a
prolonged history of use, a reasonable but not proven theoretical basis, a low
complication rate, and conflicting evidence of efficacy. The authors concluded
that, at this time, there is no evidence supporting the efficacy of prolotherapy
injections alone without cointerventions. Studies are needed to establish the
safety of common prolotherapy solutions and to determine the optimum dose
and number of injection sessions required.
Ferna´ndez-Fairen M, Sala P, Dufoo M Jr, Ballester J, Murcia A, Merzthal L.
Anterior cervical fusion with tantalum implant: a prospective randomized
controlled study. Spine. 2008;33:465-72.
In this prospective randomized study, the use of a tantalum implant
was compared with the use of iliac bone graft and plating after one-level
anterior discectomy. The early results associated with the tantalum implant
were equivalent to or slightly better than those associated with iliac bone-
grafting and an anterior plate. At twenty-four months, the outcomes for the
two groups were identical. It is hoped that the authors will follow these patients
for a minimum of five years.
Gay RE, Brault JS. Evidence-informed management of chronic low back pain
with traction therapy. Spine J. 2008;8:234-42.
This paper summarizes the best available evidence regarding the use of
traction therapy for the treatment of chronic low-back pain. The preponder-
ance of evidence indicates that sustained traction is ineffective for the treat-
ment of low-back pain with or without leg pain. Although proprietary traction
machines theoretically allow the spine to be distracted without reactive muscle
contraction, allowing better separation of the vertebrae, there is little evidence
that the result truly differs from that associated with simple intermittent axial
traction.
Glassman SD, Carreon LY, Djurasovic M, Campbell MJ, Puno RM, Johnson
JR, Dimar JR. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a
randomized, controlled trial in patients over sixty years of age. Spine.
2008;33:2843-9.
The authors report the results of a prospective randomized controlled
trial in which rhBMP-2 on an absorbable collagen sponge (ACS) was compared
with iliac crest bone graft for lumbar spine fusion in 102 patients over the age
of sixty years. The mean fusion grade on a computed tomography scan was
significantly better in the rhBMP-2/ACS group. The total cost of care over two
years was $2000 greater in the iliac crest bone graft group. This was a physician-
directed study of an off-label use that appears to have better outcomes at a
comparable or slightly lower cost. There was one nonunion in the rhBMP-2
group, compared with five nonunions in the iliac crest bone graft group. Time
and additional studies will define the appropriate and safe use of such bio-
logics. In the meantime, care must be exercised with the off-label use of BMP
to minimize the risk of inconsistent bone formation or local side effects.
Graham N, Gross A, Goldsmith CH, Klaber Moffett J, Haines T, Burnie SJ,
Peloso PM. Mechanical traction for neck pain with or without radiculopathy.
Cochrane Database Syst Rev. 2008;3:CD006408.
The authors performed a systematic review with use of the Cochrane
method and could not find any evidence that supports or refutes the use of
cervical traction for patients with neck pain or radiculopathy. Although many
studies have shown improvement in association with this modality, the pres-
ence of potential bias, poor reporting of methods, and inadequate outcome
measures precluded their use in this review.
Henschke N, Maher CG, Refshauge KM. A systematic review identifies five
‘‘red flags’’ to screen for vertebral fracture in patients with low back pain. J Clin
Epidemiol. 2008;61:110-8.
A systematic review of the literature on the diagnosis of vertebral body
fractures in patients with low-back pain was performed. Twelve studies were
reviewed that characterized fifty-one clinical features to assess the accuracy of
diagnosis. Five clinical features were found to be useful to increase or decrease
the probability of the presence of a fracture: an age of more than fifty years,
female sex, the presence of major trauma, pain and tenderness, and a dis-
tracting painful injury. These five clinical features may be useful for screening
patients with low-back pain for the presence of a vertebral body fracture.
Imamura M, Furlan AD, Dryden T, Irvin E. Evidence-informed management
of chronic low back pain (CLBP) with massage. Spine J. 2008;8:121-33.
This paper summarizes the best available evidence for the use of
massage for chronic low-back pain, and there is strong evidence that massage is
effective. Massage is beneficial for patients with chronic-low back pain in terms
of improving symptoms and function. Although massage therapy may appear
costly, it may save money by reducing health-care provider visits, the use of
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pain medications, and the costs of back-care services. However, there is a
paucity of high-quality studies that assess the cost-effectiveness of massage
therapy.
Jirarattanaphochai K, Thienthong S, Sriraj W, Jung S, Pulnitiporn A,
Lertsinudom S, Foocharoen T. Effect of parecoxib on postoperative pain after
lumbar spine surgery: a bicenter, randomized, double-blinded, placebo-
controlled trial. Spine. 2008;33:132-9.
A prospective randomized trial of the effect of parecoxib on postop-
erative pain after lumbar fusion, discectomy, or decompression was performed
on 120 patients. Forty patients in each surgical group were randomized to
receive either placebo or multidoses of parecoxib, and the use of morphine
administered by means of patient-controlled anesthesia was monitored. The
overall effects in patients receiving parecoxib and morphine were comparable
with those in patients receiving morphine alone. The patients receiving
parecoxib had significantly improved postoperative pain control with a
reduction in opioid requirement, lower pain scores, and a higher subjective
rating of the medication.
Marshall P, Murphy B. Self-report measures best explain changes in disability
compared with physical measures after exercise rehabilitation for chronic low
back pain. Spine. 2008;33:326-38.
This study examined sixty individuals with chronic low-back pain who,
after receiving four weeks of manipulative or nonmanipulative treatment, were
assigned to receive either a supervised Swiss ball exercise program or advice
alone. Greater improvement in terms of self-rated disability after the treatment
period was noted for the individuals who received supervised exercise as
compared with those who received advice alone. The authors concluded that
use of supervised exercise is more successful than advice therapy and that these
differences are primarily in psychological self-reported measures rather than
actual physical measurements.
Martimo KP, Verbeek J, Karppinen J, Furlan AD, Takala EP, Kuijer PP,
Jauhiainen M, Viikari-Juntura E. Effect of training and lifting equipment for
preventing back pain in lifting and handling: systematic review. BMJ.
2008;336:429-31.
This study, performed in Finland, concluded that there is no evidence
to support the use of advice or training in working techniques for preventing
back pain or consequent disability. The methods were good, and the results
were disappointing.
Mayer J, Mooney V, Dagenais S. Evidence-informed management of chronic
low back pain with lumbar extensor strengthening exercises. Spine J.
2008;8:96-113.
This study specifically examined the evidence regarding the treatment of
chronic low-back pain with lumbar extensor strengthening exercises. The authors
found that, in the short-term, lumbar extensor strengthening exercise adminis-
tered alone or with cointerventions is more effective than no treatment and most
passive modalities for achieving improvements in terms of pain, disability, and
other patient-reported outcomes in patients with chronic low-back pain.
Novak S, NemethWC. The basis for recommending repeating epidural steroid
injections for radicular low back pain: a literature review. Arch Phys Med
Rehabil. 2008;89:543-52.
A systematic review was performed to determine the efficacy of repeat
epidural steroid injections for the treatment of radicular low-back pain. The
study objectives failed because of the lack of available quality studies. The
authors concluded correctly that no evidence exists to support the use of
additional injections, and they recommended additional, more rigorous,
investigations.
Poitras S, Brosseau L. Evidence-informed management of chronic low back
pain with transcutaneous electrical nerve stimulation, interferential current,
electrical muscle stimulation, ultrasound, and thermotherapy. Spine J.
2008;8:226-33.
This study specifically examined the evidence on the treatment of
chronic low-back pain with transcutaneous electrical nerve stimulation, in-
terferential current, electrical muscle stimulation, ultrasound, and thermo-
therapy. The authors found that there are few studies to support the use of
these methods for the treatment of chronic low-back pain. Many of the studies
were of poor quality, and many had differing results. Studies both for and
against these treatments were found.
Rasmussen S, Krum-Møller DS, Lauridsen LR, Jensen SE, Mandøe H, Gerlif
C, Kehlet H. Epidural steroid following discectomy for herniated lumbar disc
reduces neurological impairment and enhances recovery: a randomized study
with two-year follow-up. Spine. 2008;33:2028-33.
Two hundred patients who had been managed with lumbar discectomy
were randomized to treatment with or without an epidural steroid and were
followed for two years. No infections were registered. The authors concluded
that epidural methylprednisolone enhanced recovery after discectomy for the
treatment of a herniated disc, without apparent side effects. The main con-
clusion was that the hospital stay was reduced from eight to six days. In North
America, the usual hospital stay after an unremarkable discectomy is typically
only one or two days.
Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Non-steroidal
anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev.
2008;1:CD000396.
The authors performed a meta-analysis on twenty-eight high-quality
trials comparing nonsteroidal anti-inflammatory drugs that are used for the
treatment of acute and chronic back pain. They found significant pain re-
duction at one week in association with nonsteroidal anti-inflammatory drugs
as compared with placebo, at the expense of a higher rate of adverse events.
COX2 nonsteroidal anti-inflammatory drugs were equally effective but
had fewer side effects. However, the effect size of the nonsteroidal anti-
inflammatory drugs was small and was unlikely to be greater than that of
acetaminophen, physical therapy, or manipulation.
Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V,
Herold M, Kvien TK, Mielants H, Mendoza JM, Olivieri I, Østergaard M,
Schachna L, Sieper J, Boumpas DT, Dougados M. Evidence-based recom-
mendations for the management of ankylosing spondylitis: systematic literature
search of the 3E Initiative in Rheumatology involving a broad panel of experts and
practising rheumatologists. Rheumatology (Oxford). 2008;47:355-61.
This was a ten-country discussion of the evidence regarding treatment
recommendations for ankylosing spondylitis. An international panel of experts
analyzed 467 reports and developed twelve key recommendations for treat-
ment, stratified into three general diagnostic recommendations, three
recommendations concerning monitoring of disease activity, and six recom-
mendations concerning pharmacological treatment. The agreement of these
experts ranged from 72% to 93%. This is a unique method of combining
opinions of practicing rheumatologists to develop guidelines with a high de-
gree of agreement and could be expanded to even larger groups of clinicians.
Standaert CJ, Weinstein SM, Rumpeltes J. Evidence-informed management
of chronic low back pain with lumbar stabilization exercises. Spine J.
2008;8:114-20.
This review specifically examined the evidence on the treatment of
chronic low back pain with lumbar stabilization exercises. The studies that
were examined typically had a mixed group of patients with nonspecific
chronic low-back pain, with or without radicular symptoms, so it is difficult to
draw specific conclusions. The authors found that lumbar stabilization exer-
cises are effective for reducing pain and improving function in such hetero-
geneous groups of patients.
van den Hout WB, Peul WC, Koes BW, Brand R, Kievit J, Thomeer RT;
Leiden-The Hague Spine Intervention Prognostic Study Group. Prolonged
conservative care versus early surgery in patients with sciatica from lumbar disc
herniation: cost utility analysis alongside a randomised controlled trial. BMJ.
2008;336:1351-4.
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A previously published randomized controlled study in which surgery was
compared with prolonged nonoperative care was secondarily examined for cost
utility of treatment. The quality-adjusted life years (QALYS) were determined
from standard outcome instruments. Costs were determined from health care
utilization, patients’ diaries, and work productivity. Surgery had higher costs that
were offset by earlier return to work and therefore was considered to be cost-
effective. These results are reassuring, especially considering the high rate of
crossover and the selection bias of patients entering the study, which biased the
original randomized controlled trial toward nonoperative care.
Van der Roer N, van Tulder M, van Mechelen W, de Vet H. Economic
evaluation of an intensive group training protocol compared with usual care
physiotherapy in patients with chronic low back pain. Spine. 2008;33:445-51.
In this prospective randomized study from The Netherlands, the cost-
effectiveness of an intensive group-training protocol was compared with that of
standard physical therapy in patients with nonspecific chronic low-back pain.
The intensive group-training protocol combines exercise therapy, back school,
and behavioral principles. At one year, the direct health-care costs were sig-
nificantly higher for the protocol group, with small and insignificant differ-
ences in outcome between the groups.
Wai EK, Rodriguez S, Dagenais S, Hall H. Evidence-informed management of
chronic low back pain with physical activity, smoking cessation, and weight
loss. Spine J. 2008;8:195-202.
This review specifically examined the evidence on the treatment of
chronic low-back pain with physical activity, smoking cessation, and weight loss.
There were a limited number of articles, many of which were of low quality, but
the authors concluded that there was no evidence as to the efficacy of smoking
cessation or nonoperative weight loss as treatments for chronic low-back pain.
There was moderate evidence that different types of physical activity were more
effective than no activity for longer-term reductions in disability and im-
provements in terms of worst pain, medication usage, work status, and mood.
Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Blood E, Hanscom B,
Herkowitz H, Cammisa F, Albert T, Boden SD, Hilibrand A, Goldberg H,
Berven S, An H; SPORT Investigators. Surgical versus nonsurgical therapy for
lumbar spinal stenosis. N Engl J Med. 2008;358:794-810.
The authors report on one cohort from a large prospective randomized
surgery trial evaluating outcomes for patients with a chief complaint of leg pain
(neurogenic claudication) resulting from the confirmed diagnosis of lumbar
spinal stenosis without spondylolisthesis. Two hundred and eighty-nine pa-
tients were randomized to decompression surgery or usual nonsurgical care,
and an additional 365 patients were enrolled into an observational cohort. In
the combined as-treated analysis, patients who underwent surgery showed
significantly more improvement in all primary outcomes than did patients who
were managed nonsurgically. The detailed information in this study should
help physicians to advise patients about the decision to have surgery and the
expected outcomes when leg pain has persisted for at least twelve weeks in the
presence of lumbar spinal stenosis.
Yee AJ, Yoo JU, Marsolais EB, Carlson G, Poe-Kochert C, Bohlman HH,
Emery SE. Use of postoperative lumbar corset after lumbar spinal arthrodesis
for degenerative conditions of the spine. A prospective randomized trial. J Bone
Joint Surg Am. 2008;90:2062-8.
In this prospective randomized trial, the use of a postoperative
lumbar corset for eight weeks following a posterior lumbar arthrodesis for
the treatment of a degenerative spinal condition was compared with the use
of no corset. There was no significant advantage or disadvantage to the use
of a postoperative lumbar corset following spinal arthrodesis for the
treatment of degenerative conditions of the lumbar spine. Perhaps patient
desire and comfort should dictate this decision in the absence of additional
data.
Yuan J, Purepong N, Kerr DP, Park J, Bradbury I, McDonough S. Effec-
tiveness of acupuncture for low back pain: a systematic review. Spine.
2008;33:E887-900.
The authors present a systematic review of randomized controlled
trials to explore the evidence on the effectiveness of acupuncture for the
treatment of nonspecific low-back pain. Twenty-three studies were included,
six of which were of high quality. The authors concluded that acupuncture can
be a useful supplement to other forms of conventional therapy for the treat-
ment of nonspecific low-back pain, but the effectiveness of acupuncture
compared with other forms of conventional therapies still requires further
investigation.
1834
TH E J O U R N A L O F B O N E & JO I N T SU R G E RY d J B J S . O R G
VO LU M E 91-A d NU M B E R 7 d J U LY 2009
WH AT ’ S NE W I N SP I N E SU R G E RY
What’s New in Spine Surgery
